ArticleFrontiers in immunology2025

Pan-cancer analysis identifies tRNA modification enzyme CTU2 as a novel tumor biomarker and its role in immune microenvironment.

Jiaojiao Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.